Veeva Systems

Veeva Systems operates as a Public Benefit Corporation providing cloud-based software, data, and business consulting exclusively for the life sciences industry. The company's platform spans the entire drug development and commercialization lifecycle, from clinical trials through regulatory approval to commercial launch and ongoing market operations.

The company organizes its offerings across six core solution areas: Clinical (including EDC, CTMS, eTMF, and site connectivity), Regulatory (submissions and registrations management), Quality (QMS and documentation), Safety (pharmacovigilance and adverse event management), Medical Affairs (KOL engagement and medical communications), and Commercial (CRM, marketing, and analytics). All solutions are built on the unified Vault platform architecture.

Veeva has established significant market presence with 85% of newly approved drugs launched using its platform. The company maintains long-term strategic partnerships with major pharmaceutical companies including BioMarin, Amgen, and IQVIA, and has recently introduced AI agents to increase productivity in regulatory and commercial processes.

Choose Veeva when your organization requires proven, industry-standard software for life sciences operations with strong regulatory compliance capabilities. Their platform excels for companies managing complex clinical trials, multi-country regulatory submissions, or commercial operations requiring HCP engagement tracking and content management.

Expect a partnership-oriented approach with extensive implementation support, education services, and an active user community. The company's PBC structure and long-term client relationships (evidenced by multi-year strategic partnerships) indicate commitment to customer success beyond software licensing.

Veeva serves exclusively the life sciences sector of healthcare, focusing on companies that develop and commercialize pharmaceuticals, biologics, medical devices, and consumer health products. The company demonstrates deep regulatory expertise across FDA, EMA, and global health authority requirements, with solutions specifically designed for GxP compliance, pharmacovigilance regulations, and promotional review processes.

Their platform addresses industry-specific workflows including clinical trial site connectivity, eTMF management aligned with ICH guidelines, regulatory submission publishing in eCTD format, adverse event reporting compliant with E2B standards, and commercial operations governed by sunshine act disclosure requirements.

Pharmaceutical, biotechnology, or medical device companies with active clinical development programs, complex regulatory requirements across multiple markets, or large commercial operations requiring compliant HCP engagement. Organizations seeking to consolidate disparate clinical, regulatory, quality, or commercial systems onto a unified platform architecture benefit most from Veeva's integrated approach.